Encyclopedia, Vol. 3, Pages 1345-1357: Gene Editing: The Regulatory Perspective

11 months ago 17

Encyclopedia, Vol. 3, Pages 1345-1357: Gene Editing: The Regulatory Perspective

Encyclopedia doi: 10.3390/encyclopedia3040096

Authors: Sarfaraz K. Niazi

Gene or genome editing, often known as GE, is a technique utilized to modify, eliminate, or substitute a mutated gene at the DNA level. It serves as a valuable tool in the field of genetic manipulation. Gene therapy (GT) is a therapeutic approach that aims to correct mutations by delivering a functional gene copy into the body. In contrast, the mutated gene remains in the genome. It is considered a form of medical intervention. No approval has been granted for any product manufactured by GE, in contrast to the approval of 22 medications produced by GT. These GT products are priced at millions of US dollars each dose. The Food and Drug Administration (FDA) has recently implemented a guideline about gene editing, which aims to facilitate the expedited creation of genetically engineered (GE) goods. However, the FDA must provide further elucidation and necessary revisions to enhance the rationality of this guideline.

Read Entire Article